Wegovy Coupon & Prices
Get notified when Wegovy medication is added to NiceRxGet Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
Wegovy manufacturer coupon
Prescription drug coupons are provided by manufacturers to help individuals save on their medications. Sign up to find out if you are eligible to receive a Wegovy Savings Card and pay as low as $25 for your Wegovy 1-month supply (1 box) up to a maximum benefit of $200 per 1-month supply if you have private or commercial insurance with coverage, or save up to $500 per 1-month supply (1 box) if you pay cash for your prescriptions or your commercial insurance doesn’t cover the cost of Wegovy. To find out if you are eligible, view details and read the requirements carefully to ensure you are qualified.
Is NiceRx a Wegovy coupon provider?
We do not offer printable Wegovy manufacturer coupons, Wegovy discounts, or free Wegovy samples. We are not a Wegovy coupon provider or Wegovy discount card.
Wegovy patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Wegovy cheaper if I have insurance?
How much does Wegovy cost without insurance?
Wegovy cost without insurance will vary depending on where you buy it. As a guide, Wegovy subcutaneous solution (0.25 mg/0.5 mL (0.25 mg dose) usually costs $1,400 for 2 milliliters.
How much does Wegovy cost with insurance?
The copay for Wegovy with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.
What is Wegovy?
Wegovy is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Novo Nordisk, Inc. Wegovy is a higher-dose, 2.4 mg version of the diabetes drug Ozempic (semaglutide).
It is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with a body mass index (BMI):
- 30 kg/m2 or greater (obesity)
- 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity condition such as hypertension, type 2 diabetes mellitus, or dyslipidemia
Wegovy should not be used in combination with other semaglutide containing products or any other GLP-1 receptor agonist. The safety and efficacy of use with other products for weight loss have not been established. Also, Wegovy has not been studied in patients with a history of pancreatitis.
Semaglutide causes thyroid C-cell tumors in rodents at clinically relevant levels. It is not known if wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.
Wegovy is not recommended in patients with a personal or family history of MTC or in patients with Multiple endocrine neoplasia syndrome type 2. It is important to know of the potential risk of MTC and symptoms of thyroid tumors.
What doses of Wegovy are available?
Wegovy is available in prefilled injection form, in the following doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg.
Wegovy should be used once weekly, on the same day each week, at any time of day, with or without meals. Inject subcutaneously in the abdomen, thigh, or upper arm.
Start at 0.25 mg once weekly for 4 weeks. Increasing the dose 4 weekly until a dose of 2.4 mg is reached. The maintenance dose of Wegovy is 2.4 mg once weekly.
See the full prescribing information for the complete boxed warning. You are recommended to read the medication guide and advised to always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Wegovy active ingredients
Wegovy contains semaglutide as the active ingredient.
Wegovy side effects
The most common side effects of Wegovy in clinical trials compared to placebo include:
- Nausea, vomiting
- Diarrhea, constipation, abdominal pain
- Headache, dizziness
- Dyspepsia, abdominal distension, eructation
- Hypoglycemia (low blood sugar) in patients with type 2 diabetes
- Flatulence, gastroenteritis, and gastroesophageal reflux disease (heartburn)
In rare instances, Wegovy can cause more serious side effects. These can include:
- Thyroid C-cell tumors
- Acute pancreatitis
- Acute gallbladder disease
- Acute kidney injury – monitor renal function when initiating or escalating doses if severe adverse gastrointestinal reactions occur
- Diabetic retinopathy complications in patients with Type 2 Diabetes
- Heart rate increase
- Suicidal behavior and ideation
Your doctor will assess the benefits of using Wegovy against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Wegovy to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Wegovy drug interactions
Wegovy can interact with other medications. These include:
- Concomitantly administered oral medications – may affect absorption
This list is not exhaustive and other prescription drugs may interact with Wegovy. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Wegovy if you:
- Are allergic to the active ingredient semaglutide
- Are allergic to any of the other ingredients in Wegovy
- Have a family history of medullary thyroid carcinoma
- Have multiple endocrine neoplasia syndrome type 2
- Are pregnant or are planning to become pregnant
Talk to your doctor about your health issues before using Wegovy if you:
- Are taking any of the medications that could interact with Wegovy
- Are breastfeeding or are planning to breastfeed – it is unknown if this medication passes into breast milk
Wegovy is the trademark brand name for semaglutide manufactured by Novo Nordisk, Inc. A generic version of semaglutide is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Wegovy savings through NiceRx.
Wegovy research & news
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.